{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:23:33Z","timestamp":1768019013474,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12185-023-03607-w","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T15:02:36Z","timestamp":1682348556000},"page":"503-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Newly diagnosed extranodal NK\/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-0568","authenticated-orcid":false,"given":"Takuto","family":"Tachita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"issue":"5","key":"3607_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41591-021-01316-7","volume":"27","author":"M Levine-Tiefenbrun","year":"2021","unstructured":"Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med. 2021;27(5):790\u20132.","journal-title":"Nat Med"},{"issue":"27","key":"3607_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"25","key":"3607_CR3","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","volume":"121","author":"E Tse","year":"2013","unstructured":"Tse E, Kwong YL. How i treat NK\/T-cell lymphomas. Blood. 2013;121(25):4997\u20135005.","journal-title":"Blood"},{"issue":"5","key":"3607_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2009","unstructured":"Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. 2009;21(5):1032\u201340.","journal-title":"Ann Oncol"},{"issue":"4","key":"3607_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12185-019-02609-x","volume":"109","author":"M Yamaguchi","year":"2019","unstructured":"Yamaguchi M, Suzuki R. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-9. Extranodal NK\/T-cell lymphoma, nasal type (ENKL). Int J Hematol. 2019;109(4):371\u20136.","journal-title":"Int J Hematol"},{"key":"3607_CR6","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"S Swerdlow","year":"2016","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2016."},{"issue":"2","key":"3607_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.7774\/cevr.2022.11.2.222","volume":"11","author":"A Herzum","year":"2022","unstructured":"Herzum A, Trave I, D\u2019Agostino F, Burlando M, Cozzani E, Parodi A. Epstein\u2013Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report. Clin Exp Vaccine Res. 2022;11(2):222.","journal-title":"Clin Exp Vaccine Res"},{"issue":"33","key":"3607_CR8","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol. 2011;29(33):4410\u20136.","journal-title":"J Clin Oncol"},{"key":"3607_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100774","volume":"34","author":"E Ammirati","year":"2021","unstructured":"Ammirati E, Cavalotti C, Milazzo A, Pedrotti P, Soriano F, Schroeder JW, et al. Temporal relation between second dose BNT162b2 mRNA COVID-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. IJC Hear Vasc. 2021;34: 100774.","journal-title":"IJC Hear Vasc"},{"issue":"4","key":"3607_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","volume":"46","author":"G Xu","year":"2021","unstructured":"Xu G, Lu Y. COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT. Clin Nucl Med. 2021;46(4):353\u20134.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"3607_CR11","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1080\/10428194.2021.1924371","volume":"62","author":"CM Brumfiel","year":"2021","unstructured":"Brumfiel CM, Patel MH, DiCaudo DJ, Rosenthal AC, Pittelkow MR, Mangold AR. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination. Leuk Lymphoma. 2021;62(10):2554\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3607_CR12","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1111\/jdv.17736","volume":"36","author":"E Panou","year":"2022","unstructured":"Panou E, Nikolaou V, Marinos L, Kallambou S, Sidiropoulou P, Gerochristou M, et al. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination. J Eur Acad Dermatology Venereol. 2022;36(2):e91\u20133.","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"8","key":"3607_CR13","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1111\/jdv.18136","volume":"36","author":"M Mizutani","year":"2022","unstructured":"Mizutani M, Mitsui H, Amano T, Ogawa Y, Deguchi N, Shimada S, et al. Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccination. J Eur Acad Dermatology Venereol. 2022;36(8):e613\u20135.","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"4","key":"3607_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1067\/mjd.2001.114751","volume":"45","author":"Y Tokura","year":"2001","unstructured":"Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein\u2013Barr virus-associated natural killer cell leukemia\/lymphoma. J Am Acad Dermatol. 2001;45(4):569\u201378.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3607_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein\u2013Barr virus infection. Blood. 2001;98(2):280\u20136.","journal-title":"Blood"},{"issue":"3","key":"3607_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"1","key":"3607_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3343\/alm.2020.40.1.80","volume":"40","author":"S Lee","year":"2020","unstructured":"Lee S, Park C-J, Cho Y-U, Jang S, Huh J, Kim H. The first Korean case of Epstein\u2013Barr virus-positive Natural Killer\/T-cell lymphoma that progressed from severe mosquito bite allergy, with coexistence of hemophagocytic lymphohistiocytosis. Ann Lab Med. 2020;40(1):80\u20133.","journal-title":"Ann Lab Med"},{"issue":"3","key":"3607_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/pde.14877","volume":"39","author":"E Dupuy","year":"2022","unstructured":"Dupuy E, Afifi L, Jonas SJ, Cheng CE, Hogeling M. A case of severe mosquito bite allergy complicated by fatal hemophagocytic lymphohistiocytosis. Pediatr Dermatol. 2022;39(3):443\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"3607_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-021-01100-7","volume":"14","author":"LV Tang","year":"2021","unstructured":"Tang LV, Hu Y. Hemophagocytic lymphohistiocytosis after COVID-19 vaccination. J Hematol Oncol. 2021;14(1):87.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3607_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/vaccines10040573","volume":"10","author":"TY Lin","year":"2022","unstructured":"Lin TY, Yeh YH, Chen LW, Cheng CN, Chang C, Roan JN, et al. Hemophagocytic lymphohistiocytosis following BNT162b2 mRNA COVID-19 vaccination. Vaccines. 2022;10(4):573.","journal-title":"Vaccines"},{"issue":"1","key":"3607_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","volume":"88","author":"S Ishihara","year":"1997","unstructured":"Ishihara S, Ohshima K, Tokura Y, Yabuta R, Imaishi H, Wakiguchi H, et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein\u2013Barr viral DNA-positive Natural Killer Cells. Jpn J Cancer Res. 1997;88(1):82.","journal-title":"Jpn J Cancer Res"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03607-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:18:35Z","timestamp":1695730715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03607-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3607"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03607-w","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient gave his informed consent for this case report to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}